Intuitive Surgical beat earnings estimates and saw 21.4% revenue growth in Q2, driven by its robotic systems.

Intuitive Surgical reported strong second-quarter results with EPS of $2.19, beating estimates by $0.26, and revenue of $2.44 billion, up 21.4% year-over-year, driven by its da Vinci and Ion systems. Institutional ownership remains high at 83.64%, with firms like Mitchell Sinkler & Starr PA and LRI Investments LLC increasing stakes, while Robertson Stephens Wealth Management LLC reduced its position. Insider selling totaled $21.7 million in 90 days, including significant sales by EVP Myriam Curet and Director Amy L. Ladd. Analysts maintain a "Moderate Buy" consensus with a $589.43 average price target, and the stock has a market cap of $154 billion and a P/E ratio of 59.91.